Chimeric antigen receptor‐modified macrophages trigger systemic anti‐tumour immunity

Citations Over TimeTop 10% of 2020 papers

Abstract

Preliminary results and emerging data have shown that lipid droplet high (LDhi ) immunosuppressive cells accumulate in tumour tissues. By tracking and phenotypic profiling of LDhi cells, we find that LDhi CD19+ , LDhi CD11b+ , and LDhi Ly6G+ immune cell populations appear in the spleen, thymus, and tumour tissues in a syngeneic tumour model. Using a contact-dependent reporter system, we discover a LDhi CCR7hi immunosuppressive cell population that migrates from tumour tissues to the spleen and thymus. Hence, we engineered a family of chimeric antigen receptor-modified macrophages (CAR-Ms) that direct macrophages to CCR7-positive cells and show that the cytosolic domain from Mer receptor tyrosine kinase (MerTK) triggers tumour cell cytotoxicity by the CAR-Ms. In vivo, CCR7-targeted CAR-Ms suppressed tumour growth and prolonged survival by preventing metastasis and by inducing systemic anti-tumour immunity through retarding the migration of LDhi CCR7hi immunosuppressive cells from tumour tissues to distal immune organs, indicating an important role for CCR7 in tumour cell-induced immune tolerance. © 2020 The Pathological Society of Great Britain and Ireland. Published by John Wiley & Sons, Ltd.

Related Papers

• → Probiotics Mechanism of Action on Immune Cells and Beneficial Effects on Human Health(2023)724 cited
• → Acquired immunity toSchistosoma mansoniin the rat: measurement of immunity by the lung recovery technique(1974)64 cited
• → Prostaglandins and the immune response(1977)174 cited
• → Effect of stress on immune function, allergy, and health(2000)
• Research Progress of Immune Cell Function in Patients with Recurrent Genital Herpes(2012)